|
|
|
|
| Advertisement |
 |
|
|
| Top Story |
 |
|
Biopharma Business Health Check |
The increase in new drug approvals and candidates in development are good signs for pharma and biotech, but both sectors face continued pricing, cost, and healthcare policy-related challenges ahead. Peter Young reports.
… /Read more/ |
|
|
| Advertisement |
Patient Assistance Centers of Excellence: The Next Generation of Brand Support
Wednesday, November 14th at 11:00 AM EST
 Register Now
|
|
| Advertisement |
Bringing Intelligence to Drug Discovery—The Importance of Contextual Information at All Levels
On Demand
 Learn More
|
|
|
| Calendar |
|
/ December 3–4: Digital Therapeutics / |
|
New York City, NY |
|
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
|
Philadelphia, PA |
|
/ December 5–6: Supporting the Patient Experience / |
|
Philadelphia, PA |
|
/ December 12: Specialty Product Data Strategies / |
|
Philadelphia, PA |
|
/ January 22–23, 2019: 14th Biosimilars Summit
/ |
|
Alexandria, VA |
|
/ January 23–24, 2019: Data Analytics and Decisions
/ |
|
Philadelphia, PA |
|
/ March 4–6, 2019: 20th Annual Patient Assistance and Access Programs – PAP 2019
/ |
|
Baltimore, MD |
|
|
|
|
|
|
| Advertisement |
Seizing Opportunities in Japan, the Second Largest Innovation-Driven Pharmaceutical Market
On Demand
 Learn More
|
|
| Audio |
 |
|
Pharm Exec Podcast: How a CEO Pivots Her Company and Career |
Christen and Michelle talk with Mei Mei Hu, CEO of United Neuroscience, about how being open to pivoting from your original plan can create a number of opportunities for an executive and their company, as well as how her executive team successfully manages a remote workforce spread across three continents.
… /Read More/ |
|
|
|
| Industry update |
| //
BioScience Managers (London, UK and Melbourne, Australia) appointed Dr. Kate Rowley as UK-based Investment Director.
//
Crescendo Biologics (Cambridge, UK) appointed Dr Richard Williams as SVP CMC and Development, as well as a strategic CDMO partner for its lead program, CB307.
Destiny Pharma (Brighton, UK) appointed Shaun Claydon as Chief Financial Officer and Company Secretary.
//
SGD Pharma (Paris, France) named Christophe Nicoli as its new Chief Executive Officer.
//
Zelluna Immunotherapy (Oslo, Norway) appointed Geir Christian Melen as Chief Financial Officer.
//
Orexo (Uppsala, Sweden) named Joseph DeFeo as the company's new Chief Financial Officer from November 1, 2018. Mr. DeFeo will succeed Henrik Juuel who will join the Danish company Bavarian Nordic as their new CFO.
//
AC Immune (Lausanne, Switzerland) announced that Dr. Andreas Muhs, Chief Scientific Officer, is taking a medical leave of absence. AC Immune's research team will be led by Dr. David Lowe on an interim basis.
|
|
|
